对标有astatine-211的酸衍生物进行评估,以改善体内稳定性
Mutsuho Murata1, Kento Kannaka1, Souta Tatsuta1
1Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8675, Japan.
Nuclear medicine and biology
|October 7, 2025
概括
在astatine-211 (211At) astatobenzene部分附近引入重的D-氨基酸可以增强对体内脱的稳定性. 这一策略通过防止酶介导的分解来改善向的α治疗药物.
科学领域:
- 核医学就是核医学.
- 放射性药物化学 放射性药物化学
- 有机化学 有机化学
背景情况:
- 阿斯-211 (Astatine-211 (211At)) 是针对性阿尔法疗法的有前途的阿尔法发射剂.
- 当前的标签剂,衍生物,由于脱,在体内稳定性较差.
- 假设酶介导的脱化会导致不稳定.
研究的目的:
- 为了研究是否在211-阿斯塔托烯部分附近结合庞大的结构可以提高稳定性.
- 为了开发更稳定的标记化合物用于向的α疗法.
主要方法:
- 合成含有D-氨基酸 (D-谷氨酸,D-氨酸,D-氨酸,D-氨酸) 的寡.
- 这些的结合与At-astatobenzoate.
- 结果标记的化合物在体内稳定性的评估,以防止脱.
主要成果:
- 标有单-至二-D-谷氨酸和三-D-氨酸的化合物显示了中度至高的胃和甲状腺放射性.
- 在这些器官中标记的tri-D-glutamic acid和tri-D-lysine呈现出低放射性.
- 酶介导的脱可能是由于代谢到更小的分子,而不是At-C键的弱点.
结论:
- 在211-astatobenzene部分附近的三体大小结构的固体阻碍可以在体内产生稳定的211-标记化合物.
- 这种方法提供了一种策略,以克服当前211标签部分的局限性.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
196
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
196
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
178
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
178
Drug Product Stability
226
The long-term stability of drug products is critical to ensuring their quality, safety, and effectiveness over time. Stability directly influences a product's ability to maintain its intended characteristics, ensuring it performs as expected during its intended shelf life. Key attributes such as drug potency, impurities, dissolution, and other physicochemical measures of performance are tested to assess stability. These parameters indicate how well the product retains its quality over time and...
226
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K


